These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23937330)

  • 1. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
    Kellinghaus C; Berning S; Stögbauer F
    Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous lacosamide in status epilepticus and seizure clusters.
    Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
    Epilepsia; 2011 Oct; 52(10):e148-52. PubMed ID: 21801171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study.
    Miró J; Toledo M; Santamarina E; Ricciardi AC; Villanueva V; Pato A; Ruiz J; Juvany R; Falip M
    Seizure; 2013 Jan; 22(1):77-9. PubMed ID: 23127776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
    Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
    Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam.
    Chen LL; Haneef Z; Dorsch A; Keselman I; Stern JM
    Seizure; 2011 Apr; 20(3):263-5. PubMed ID: 21109468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.
    Alvarez V; Januel JM; Burnand B; Rossetti AO
    Epilepsia; 2011 Jul; 52(7):1292-6. PubMed ID: 21480881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why we prefer levetiracetam over phenytoin for treatment of status epilepticus.
    Zaccara G; Giorgi FS; Amantini A; Giannasi G; Campostrini R; Giovannelli F; Paganini M; Nazerian P;
    Acta Neurol Scand; 2018 Jun; 137(6):618-622. PubMed ID: 29624640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
    Tilz C; Resch R; Hofer T; Eggers C
    Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous lacosamide for treatment of status epilepticus.
    Kellinghaus C; Berning S; Immisch I; Larch J; Rosenow F; Rossetti AO; Tilz C; Trinka E
    Acta Neurol Scand; 2011 Feb; 123(2):137-41. PubMed ID: 20868429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam versus phenytoin in management of status epilepticus.
    Chakravarthi S; Goyal MK; Modi M; Bhalla A; Singh P
    J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
    Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
    Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of four antiepileptic drugs in status epilepticus: experience from India.
    Misra UK; Kalita J
    Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide as a new treatment option in status epilepticus.
    Höfler J; Trinka E
    Epilepsia; 2013 Mar; 54(3):393-404. PubMed ID: 23293881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
    Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
    Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
    Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical appraisal of randomized controlled trials on intravenous phenytoin in convulsive status epilepticus.
    Brigo F; Bragazzi NL; Lattanzi S; Nardone R; Trinka E
    Eur J Neurol; 2018 Mar; 25(3):451-463. PubMed ID: 29288520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus.
    Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
    Seizure; 2011 Sep; 20(7):529-32. PubMed ID: 21489827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill.
    Newey CR; Le NM; Ahrens C; Sahota P; Hantus S
    Neurocrit Care; 2017 Apr; 26(2):273-279. PubMed ID: 27844464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of benzodiazepine-refractory status epilepticus: A retrospective, cohort study.
    Rollo E; Romozzi M; Dono F; Bernardo D; Consoli S; Anzellotti F; Ricciardi L; Paci L; Sensi SL; Della Marca G; Servidei S; Calabresi P; Vollono C
    Epilepsy Behav; 2023 Mar; 140():109093. PubMed ID: 36739634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous lacosamide--an effective add-on treatment of refractory status epilepticus.
    Albers JM; Möddel G; Dittrich R; Steidl C; Suntrup S; Ringelstein EB; Dziewas R
    Seizure; 2011 Jun; 20(5):428-30. PubMed ID: 21354831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.